Desmopressin (Nocdurna and Noctiva) for Nocturnal Polyuria
					
					
                    
      			
            		
					
					
                
					Desmopressin (Nocdurna and Noctiva) for Nocturnal Polyuria
March 25, 2019 (Issue: 1568)
					The FDA has approved a sublingual tablet (Nocdurna –
Ferring) and a nasal spray (Noctiva – Avadel) formulation
of desmopressin acetate for treatment of nocturia due to
nocturnal polyuria in adults who wake up ≥2 times per
night to void....more
 
        			
        			
						
	
		
			- M Oelke et al. A practical approach to the management of nocturia. Int J Clin Pract 2017 October 5 (epub). 
- CG Kowalik et al. Nocturia: evaluation and current management strategies. Rev Urol 2018; 20:1. 
- PK Sand et al. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized,  double-blind, placebo controlled, parallel group study. J Urol 2013; 190:958. 
- JP Weiss et al. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol 2013; 190:965. 
- J Kaminetsky et al. Efficacy and safety of SER120 nasal spray in patients with nocturia: pooled analysis of 2 randomized, double-blind, placebo controlled, phase 3 trials. J Urol 2018; 200:604. 
- Approximate WAC. WAC = wholesaler acquisition cost or manufacturer's published price to wholesalers; WAC represents a published catalogue or list price and may not represent an actual transactional price. Source: AnalySource® Monthly. March 5, 2019. Reprinted with permission by First Databank, Inc. All rights reserved. ©2019. www.fdbhealth.com/policies/drug-pricing-policy.
 
	 				
					
					
					The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
					Would you like to read the rest of this article?  Gain access below.
					
						Subscribe
						
							Subscriptions to 
The Medical Letter on Drugs and Therapeutics include:
							
								- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App 
- FREE online per issue CME/CE
 
					
						Purchase this article:
						
							
								Title: Desmopressin (Nocdurna and Noctiva) for Nocturnal Polyuria
								
								Article code: 1568d
								
								
							 
							
						 
					 
					
						Gain access through your organization
						
							Ask your librarian to consider an Institutional Subscription to The Medical Letter.